Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
IPO Year:
Exchange: NYSE
Website: integer.net
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/28/2025 | $145.00 | Outperform | Raymond James |
| 2/21/2025 | Outperform → Perform | Oppenheimer | |
| 12/3/2024 | $160.00 | Overweight | Wells Fargo |
| 7/16/2024 | $135.00 | Outperform | Oppenheimer |
| 5/15/2024 | $137.00 | Buy | Truist |
| 4/15/2024 | $105.00 → $135.00 | Neutral → Buy | BofA Securities |
| 3/14/2024 | $137.00 | Buy | CL King |
| 2/6/2024 | $125.00 | Overweight | KeyBanc Capital Markets |
| 5/26/2023 | $87.00 | Equal Weight | Wells Fargo |
| 5/11/2023 | $88.00 | Neutral | Citigroup |
8-K - Integer Holdings Corp (0001114483) (Filer)
PRE 14A - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
10-K - Integer Holdings Corp (0001114483) (Filer)
8-K - Integer Holdings Corp (0001114483) (Filer)
SCHEDULE 13G/A - Integer Holdings Corp (0001114483) (Subject)
8-K - Integer Holdings Corp (0001114483) (Filer)
10-Q - Integer Holdings Corp (0001114483) (Filer)
SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. ("Eargo" or the "Company") (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the closing of the Company's rights offering as previously announced on November 29, 2022. Patient Square Capital became the Company's majority owner upon closing of the rights offering and conversion of Patient Square's senior secured convertible notes per its investment in June 2022. As previously announced, following the completion of the rights offering, Patient Square has the right to nominate a number of directors t
PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, announced today that Bill R. Sanford will be retiring as Chair of the Integer Board of Directors at the conclusion of the Company's 2022 annual meeting of stockholders, which is scheduled to be held on May 18, 2022. Commensurate with this carefully planned transition, the Board of Directors plans to appoint current long-standing Integer Board member Pamela G. Bailey to serve as the next Chair of the Board. "On behalf of the Integer Board of Directors, I wish to thank Bill for his immense contribution and insightful leadership over the past 22 ye
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
SC 13G/A - Integer Holdings Corp (0001114483) (Subject)
PLANO, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2025 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 24, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, April 24, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3120125Webcast Registration: ITGR Q1 2025 Ea
~ Strategic transaction to create revolver capacity ~~ Immediately accretive to 2025 adjusted earnings on meaningfully lower interest expense ~ PLANO, Texas, March 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the "Company") (NYSE:ITGR), a leading medical device contract development and manufacturing organization, announces the closing of its offering of $1.0 billion aggregate principal amount of 1.875% convertible senior notes due 2030 (the "Notes"). In response to strong investor demand at attractive terms, the Company upsized the initial offering of $750 million aggregate principal amount of the Notes to $875 million and the initial purchasers fully exercised their o
PLANO, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the "Company," "Integer") (NYSE:ITGR) today announced that it has priced an offering of $875.0 million aggregate principal amount of 1.875% convertible senior notes due 2030 (the "Convertible Notes"). The offering was upsized from the previously announced offering size of $750.0 million aggregate principal amount of Convertible Notes. The Company granted to the initial purchasers of the Convertible Notes an option to purchase up to an additional $125.0 million aggregate principal amount of the Convertible Notes for settlement within a 13-day period beginning on, and including, the first day on which the Convert
PLANO, Texas, March 12, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the "Company," "Integer") (NYSE:ITGR) today announced that it intends to offer, subject to market and other conditions, $750.0 million aggregate principal amount of its convertible senior notes due 2030 (the "Convertible Notes"). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an additional $125.0 million aggregate principal amount of the Convertible Notes for settlement within a 13-day period beginning on, and including, the first day on which the Convertible Notes are issued. In connection with the pricing of the Convertible Notes, the Company
~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 8% to 10% sales growth in 2025 with expanding margins ~ PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2024 Financial Results (compared to fourth quarter 2023, except as noted) Sales increased 11% to $449 million.GAAP income from continuing operations increased $6 million to $33 million, an increase of 23%. Adjusted net incom
PLANO, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the following upcoming investor conferences. Integer will participate at the 2025 Raymond James & Associates' 46th Annual Institutional Investor Conference, to be held March 3-5, 2025, in Orlando, Florida. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Wednesday, March 5, 2025, at 11:00 a.m. ET.Integer will participate at the 2025 KeyBanc Capital Markets Healthcare Forum, to be held virtually March 18-19, 2025. Integer President and Chi
Katahdin Industries, LLC is pleased to announce the sale of substantially all of the assets of Precision Coating to Integer Holdings Corporation. The transaction closed on January 7, 2025. Precision Coating provides global Medtech customers with innovative products and services to enhance the surface functionality of patient-critical products. Since 2006, Precision Coating has built a highly specialized proprietary coatings platform in the medical technology supply chain. The portfolio build, positioning and growth trajectory was accelerated through five acquisitions including CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), a merger with N2 Biomedical (2021),
PLANO, Texas, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Convention Center in Anaheim, California. Integer welcomes visitors to booth #1439 to learn more about the company's commitment to customers as their partner of choice in enhancing the lives of patients through access to innovative technologies, superior quality and dependable manufacturing to accelerate speed to market and reduce product development risk. Integer's exhibit will showcase
PLANO, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will join global medtech leaders and innovators in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting in Orlando, Florida, from Jan. 30 – Feb. 1, 2025. NANS attendees are invited to visit booth #213 to learn more about how Integer can serve as a strategic partner of choice in amplifying customers' innovation and increasing speed to market. More specifically, Integer will showcase its latest innovations and expanded capabilities in neuromodulation to enable the next
PLANO, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, February 20, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, February 20, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3120125Webcast Regis
4 - Integer Holdings Corp (0001114483) (Issuer)
3 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
4 - Integer Holdings Corp (0001114483) (Issuer)
PLANO, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2025 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 24, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, April 24, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3120125Webcast Registration: ITGR Q1 2025 Ea
~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 8% to 10% sales growth in 2025 with expanding margins ~ PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2024 Financial Results (compared to fourth quarter 2023, except as noted) Sales increased 11% to $449 million.GAAP income from continuing operations increased $6 million to $33 million, an increase of 23%. Adjusted net incom
PLANO, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, February 20, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, February 20, 2025Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 3120125Webcast Regis
~ Continued strong performance with 3Q24 financial results ~~ Raising midpoint of 2024 operating profit and EPS outlook ~ PLANO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three and nine months ended September 27, 2024. Our previously announced sale of the Electrochem business for $50 million in cash remains on track and is expected to close later this month. Except for cash flow measures, prior period amounts have been recast to exclude the Electrochem business, which is a discontinued operation, consistent with GAAP continuing operations presentation. Unless otherwise stated, all results and comparisons set forth
PLANO, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, October 24, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, October 24, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 4525826Webcast Registration: Q3 2024 Int
~ Continued strong performance with 2Q24 financial results ~~ Raising full year 2024 profit outlook ~ PLANO, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended June 28, 2024. Second Quarter 2024 Highlights (compared to Second Quarter 2023, except as noted) Sales increased 9% to $436 million, with organic growth of 5%.GAAP net income increased $7 million to $31 million, an increase of 30%. Non-GAAP adjusted net income increased $7 million to $45 million, an increase of 17%.GAAP operating income increased $14 million to $55 million, an increase of 33%. Non-GAAP adjusted operating income increased $12
PLANO, Texas, June 27, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, July 25, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (800) 715-9871International dial-in number: (646) 307-1963Conference ID: 4525826Webcast Registration: Q2 2024 Integer H
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024. First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted) Sales increased 10% to $415 million, with organic growth of 6%.GAAP net income increased $7 million to $21 million, an increase of 57%. Non-GAAP adjusted net income increased $10 million to $39 million, an increase of 33%.GAAP operating income increased $5 million to $39 million, an increase of 15%. Non-GAAP adjusted operating income increased $13 mil
PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, April 25, 2024Time: 8 a.m. CT / 9 a.m. ETDomestic dial-in number: (888) 330-3567International dial-in number: (646) 960-0842Conference ID: 9252310Webcast Registration: ITGR Q1 20
~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 9% to 11% sales growth in 2024 with expanding margins ~ PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2023 Financial Results (compared to fourth quarter 2022, except as noted) Sales increased 11% to $413 million.GAAP income from continuing operations increased $9 million to $26 million, an increase of 54%. Adjusted net income increased $1
Raymond James initiated coverage of Integer Holdings with a rating of Outperform and set a new price target of $145.00
Oppenheimer downgraded Integer Holdings from Outperform to Perform
Wells Fargo resumed coverage of Integer Holdings with a rating of Overweight and set a new price target of $160.00
Oppenheimer initiated coverage of Integer Holdings with a rating of Outperform and set a new price target of $135.00
Truist initiated coverage of Integer Holdings with a rating of Buy and set a new price target of $137.00
BofA Securities upgraded Integer Holdings from Neutral to Buy and set a new price target of $135.00 from $105.00 previously
CL King initiated coverage of Integer Holdings with a rating of Buy and set a new price target of $137.00
KeyBanc Capital Markets resumed coverage of Integer Holdings with a rating of Overweight and set a new price target of $125.00
Wells Fargo initiated coverage of Integer Holdings with a rating of Equal Weight and set a new price target of $87.00
Citigroup initiated coverage of Integer Holdings with a rating of Neutral and set a new price target of $88.00